Protective Effects of Black Cumin () and Its Bioactive Constituent, Thymoquinone Against Kidney Injury: An Aspect on Pharmacological Insights
Overview
Chemistry
Molecular Biology
Affiliations
The prevalence of chronic kidney disease (CKD) is increasing worldwide, and a close association between acute kidney injury (AKI) and CKD has recently been identified. Black cumin () has been shown to be effective in treating various kidney diseases. Accumulating evidence shows that black cumin and its vital compound, thymoquinone (TQ), can protect against kidney injury caused by various xenobiotics, namely chemotherapeutic agents, heavy metals, pesticides, and other environmental chemicals. Black cumin can also protect the kidneys from ischemic shock. The mechanisms underlying the kidney protective potential of black cumin and TQ include antioxidation, anti-inflammation, anti-apoptosis, and antifibrosis which are manifested in their regulatory role in the antioxidant defense system, NF-κB signaling, caspase pathways, and TGF-β signaling. In clinical trials, black seed oil was shown to normalize blood and urine parameters and improve disease outcomes in advanced CKD patients. While black cumin and its products have shown promising kidney protective effects, information on nanoparticle-guided targeted delivery into kidney is still lacking. Moreover, the clinical evidence on this natural product is not sufficient to recommend it to CKD patients. This review provides insightful information on the pharmacological benefits of black cumin and TQ against kidney damage.
Kim J, Chun Y, Yoon N, Kim B, Choi K, Ku S Antioxidants (Basel). 2025; 14(2).
PMID: 40002361 PMC: 11852139. DOI: 10.3390/antiox14020174.
Kasmara D, Abdullah E, Harun Z, Sari F, Abd Rashid N, Teoh S Front Pharmacol. 2025; 16:1522814.
PMID: 39925850 PMC: 11802444. DOI: 10.3389/fphar.2025.1522814.
Alipanah-Moghadam R, Aghamohammadi V, Seifi S, Esmaeili H, Noroozzadeh S, Jeddi F Sci Rep. 2025; 15(1):3233.
PMID: 39863673 PMC: 11763254. DOI: 10.1038/s41598-025-87447-0.
Crosstalk of Hyperglycaemia and Cellular Mechanisms in the Pathogenesis of Diabetic Kidney Disease.
Efiong E, Bazireh H, Fuchs M, Amadi P, Effa E, Sharma S Int J Mol Sci. 2024; 25(20).
PMID: 39456664 PMC: 11507194. DOI: 10.3390/ijms252010882.
Yan R, Yang H, Jiang X, Lai X Dokl Biochem Biophys. 2024; 518(1):442-451.
PMID: 39196533 DOI: 10.1134/S160767292460043X.